2024
An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes
Kypriotakis G, Bernstein S, Bold K, Dziura J, Hedeker D, Mermelstein R, Weinberger A. An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes. Nicotine & Tobacco Research 2024, 26: 796-805. PMID: 38214037, PMCID: PMC11190044, DOI: 10.1093/ntr/ntae005.Peer-Reviewed Original ResearchSmoking cessation treatmentChronic relapsing conditionCessation treatmentRelapsing conditionSmoking cessation clinical trialMeasures of abstinenceTobacco useAbstinence outcomesTobacco dependence treatmentTobacco abstinenceTobacco dependenceTobacco outcomesDependence treatmentTreatment studiesAbstinenceSmoking cessationClinical trialsIntervention successParticipant enrollmentSociety for ResearchNicotineLongitudinal dataResearch NetworkRemitting natureAnalysis of data
2010
Examining antidepressant drug response by smoking status: why is it important and how often is it done?
Weinberger AH, McKee SA, Picciotto MR, Mazure CM. Examining antidepressant drug response by smoking status: why is it important and how often is it done? Journal Of Psychopharmacology 2010, 25: 1269-1276. PMID: 21169392, PMCID: PMC3256572, DOI: 10.1177/0269881110389347.Peer-Reviewed Original ResearchConceptsSmoking statusImpact of smokingEffect of smokingNeurobiology of depressionAntidepressant treatment outcomeAntidepressant drug responsePharmacological intervention studiesPharmacological trialsClinical trialsTreatment outcomesMEDLINE searchNicotine dependenceSmokingTargeted treatmentIntervention studiesTreatment studiesDrug responseDepressionOutcomesTreatment researchTrialsStatusTreatmentAntidepressantsPharmacotherapy